IRS2
Insulin Receptor Substrate 2 (IRS2) is a key protein in the insulin signaling pathway, which plays a critical role in the body's metabolic and cellular growth processes. IRS2 is one of several Insulin Receptor Substrate proteins that mediate the effects of insulin and insulin-like growth factor (IGF) on various cellular functions. It is encoded by the IRS2 gene in humans.
Function[edit | edit source]
IRS2 is involved in transmitting signals from the insulin receptor and IGF receptors to the interior of the cell, influencing various physiological processes. Upon activation by insulin or IGF, IRS2 becomes phosphorylated on multiple tyrosine residues. This phosphorylation creates binding sites for various signaling proteins, leading to the activation of downstream pathways such as the PI3K/AKT signaling pathway, which is crucial for regulating glucose homeostasis, cell growth, and cell differentiation.
Clinical Significance[edit | edit source]
Alterations in IRS2 function or expression can have significant implications for human health. For example, impaired IRS2 signaling has been associated with the development of type 2 diabetes, as it can lead to insulin resistance, a condition where the body's cells become less responsive to insulin, leading to elevated blood glucose levels. Additionally, IRS2 dysregulation has been implicated in the pathogenesis of certain cancers, as its involvement in cell growth and survival pathways can contribute to tumor development and progression.
Research[edit | edit source]
Research on IRS2 has focused on understanding its role in metabolic diseases and cancer. Studies have shown that enhancing IRS2 activity or expression can improve insulin sensitivity and glucose homeostasis, suggesting potential therapeutic strategies for treating type 2 diabetes. In cancer research, efforts are directed towards understanding how IRS2-mediated signaling contributes to tumor growth and identifying ways to target these pathways for cancer therapy.
See Also[edit | edit source]
- Insulin signaling pathway
- Insulin resistance
- Type 2 diabetes
- PI3K/AKT signaling pathway
- Insulin Receptor Substrate
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD